Company Overview

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.

  • Name

    Lam Research Corporation

  • CEO

    Mr. Timothy M. Archer

  • Website

    www.lamresearch.com

  • Sector

    Semiconductors and Semiconductor Equipment

  • Year Founded

    1980

Profile

  • Market Cap

    $98.17B

  • EV

    $97.59B

  • Shares Out

    129.88M

  • Revenue

    $14.91B

  • Employees

    17,450

Margins

  • Gross

    47.61%

  • EBITDA

    31.43%

  • Operating

    29.02%

  • Pre-Tax

    29.25%

  • Net

    25.68%

  • FCF

    28.55%

Returns (5Yr Avg)

  • ROA

    23.1%

  • ROTA

    60.76%

  • ROE

    59.18%

  • ROCE

    34.82%

  • ROIC

    40.73%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $1,016.6

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $5,847.86M

  • Net Debt

    -$576.81M

  • Debt/Equity

    0.62

  • EBIT/Interest

    23.35

Growth (CAGR)

  • Rev 3Yr

    0.63%

  • Rev 5Yr

    9.08%

  • Rev 10Yr

    12.46%

  • Dil EPS 3Yr

    2.54%

  • Dil EPS 5Yr

    16.18%

  • Dil EPS 10Yr

    23.13%

  • Rev Fwd 2Yr

    17.84%

  • EBITDA Fwd 2Yr

    20.08%

  • EPS Fwd 2Yr

    23.07%

  • EPS LT Growth Est

    15.01%

Dividends

  • Yield

  • Payout

    27.46%

  • DPS

    $8

  • DPS Growth 3Yr

    15.44%

  • DPS Growth 5Yr

    12.7%

  • DPS Growth 10Yr

    46.14%

  • DPS Growth Fwd 2Yr

    5.52%

NasdaqGS:LRCX